Xellar Raises $50M Series A for AI-Powered Organ-on-Chip Drug Discovery
Xellar Biosystems raised $50M in Series A financing for its AI-powered organ-on-chip drug discovery platform — a closed-loop system that bridges biological experiments with computational modeling.